OKUR
OnKure Therapeutics, Inc.NASDAQHealthcare$4.35+1.40%ClosedMarket Cap: $59.5M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
1.05
P/S
0.00
EV/EBITDA
-0.02
DCF Value
$4.23
FCF Yield
-87.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-81.7%
ROA
-95.8%
ROIC
-110.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-14.1M | $-13.5M | $-0.99 | — |
| FY 2025 | $0.00 | -Infinity% | $-63.0M | $-59.5M | $-4.40 | — |
| Q3 2025 | $0.00 | NaN% | $-15.5M | $-14.7M | $-1.09 | — |
| Q2 2025 | $0.00 | NaN% | $-16.3M | $-15.4M | $-1.14 | — |
| Q1 2025 | $0.00 | NaN% | $-17.0M | $-15.9M | $-1.19 | — |
| Q4 2024 | $0.00 | NaN% | $-33.8M | $-35.2M | $-2.64 | — |
| FY 2024 | $0.00 | NaN% | $-54.4M | $-52.7M | $-3.95 | — |
| Q3 2024 | $0.00 | -Infinity% | $-4.7M | $-3.7M | $-0.28 | — |
| Q2 2024 | $0.00 | NaN% | $-14.3M | $-14.1M | $-1.06 | — |
| Q1 2024 | $0.00 | NaN% | $-9.8M | $-9.5M | $-0.71 | — |
| Q4 2023 | $0.00 | NaN% | $21.1M | $18.5M | $1.39 | — |
| FY 2023 | $0.00 | NaN% | $-36.9M | $-35.3M | $-2.65 | — |